0001209191-21-006700.txt : 20210202
0001209191-21-006700.hdr.sgml : 20210202
20210202145420
ACCESSION NUMBER: 0001209191-21-006700
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210131
FILED AS OF DATE: 20210202
DATE AS OF CHANGE: 20210202
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Barrett Elizabeth A.
CENTRAL INDEX KEY: 0001764157
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38079
FILM NUMBER: 21580540
MAIL ADDRESS:
STREET 1: C/O UROGEN PHARMA LTD.
STREET 2: 9 HA'TA'ASIYA STREET
CITY: RA'ANANA
STATE: L3
ZIP: 4365007
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: UroGen Pharma Ltd.
CENTRAL INDEX KEY: 0001668243
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: L3
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9 HA'TA'ASIYA ST
CITY: RA'ANANA
STATE: L3
ZIP: 4365007
BUSINESS PHONE: 972 9 770 7601
MAIL ADDRESS:
STREET 1: 9 HA'TA'ASIYA ST
CITY: RA'ANANA
STATE: L3
ZIP: 4365007
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-01-31
0
0001668243
UroGen Pharma Ltd.
URGN
0001764157
Barrett Elizabeth A.
400 ALEXANDER PARK DRIVE
PRINCETON
NJ
08540
0
1
0
0
Chief Executive Officer
Stock Option (right to buy)
22.07
2021-01-31
4
A
0
150000
0.00
A
2031-01-31
Ordinary Shares
150000
150000
D
Restricted Stock Units
2021-01-31
4
A
0
40000
0.00
A
Ordinary Shares
40000
40000
D
1/3 of the shares underlying the stock options will vest on each of January 31, 2022, January 31, 2023 and January 31, 2024
Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer.
1/3 of the shares underlying the restricted stock units will vest on each of January 31, 2022, January 31, 2023 and January 31, 2024
/s/ Jason Smith, Attorney-in-
Fact
2021-02-02